Table 4.

Percentage of individuals with good clinical outcomes, as defined by Anton et al., (2006) and the results from the current study.

Treatment group	Good clinical outcome based on Anton et al.	Infrequent drinking class based on GMM	Infrequent drinking pattern based on LMM
Placebo + MM	58.2	68.3	38.0
Naltrexone + MM	73.7	83.9	55.9
Acamprosate + MM	60.8	68.1	47.9
Naltrexone + Acamprosate + MM	78.4	85.8	54.6
Placebo + CBI	71.3	82.1	57.2
Naltrexone + CBI	74.4	80.3	57.1
Acamprosate + CBI	74.4	78.5	55.6
Naltrexone + Acamprosate + CBI	73.5	82.5	57.3
CBI only	60.6	72.8	44.9

Note. CBI = Combined Behavioral Intervention; MM = Medication Management